期刊文献+

儿科住院病例抗菌药物使用情况分析 被引量:15

Analysis of the Usage of Antibacterials in Pediatric Inpatients
暂未订购
导出
摘要 目的:了解儿科抗菌药物的应用现状,评价其使用的合理性。方法:收集我院儿科2008年5~12月出院病历2403份,回顾性分析其抗菌药物应用情况。结果:抗菌药物使用率为76.41%,病原菌检测率5.28%,头孢唑肟使用频率最高为45.43%,联合用药均为两联,联合用药率为46.57%,更换抗菌药物占6.75%。结论:我院儿科抗菌药物应用基本遵循了《抗菌药物临床应用指导原则》,但有些联用方案是否合理还有待商榷,在抗菌药物的配伍和病原菌检测上还需提高。 Objective: To investigate the situation of administration of antibiotics for child inpatients and evaluate its rationality. Methods: Two thousand four hundred and three pedatric medical records in our hospital from May to December 2008 were selected randomly and a retrospective analysis was done on the use of antibiotics. Results: The application rate of antibiotics was 76.41%, detection rate of pathogenic bacteria was 5.28%, the most frequently used antibacterial was ceftizoxime counting for 45.43%. The combination rate of antibiotics was 46.57% and the replacement of antibacterials took 6.75%. Conclusions: The use of antibiotics basically follows "The Guiding Prinple of Clinical Use of Antibacterials" in the child medication in our hospital, but some combinations of antibiotics should be discussed on their rationality and the compatibility of antibiotics and the detection of pathogenic bacteria need improving.
出处 《儿科药学杂志》 CAS 2009年第2期42-43,46,共3页 Journal of Pediatric Pharmacy
关键词 抗菌药物 联合用药 合理用药 Antibiotic Drug combination Rational use of drug
  • 相关文献

参考文献6

二级参考文献16

  • 1宋琳,瞿介明.肺炎链球菌对大环内酯类抗生素耐药的研究进展[J].中国呼吸与危重监护杂志,2003,2(5):265-267. 被引量:5
  • 2刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:792
  • 3社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3117
  • 4中华人民共和国卫生部医政司.常用耳毒性药物临床使用规范[M].北京:华夏出版社,1999.4-24.
  • 5Tiemei Z, Xiangqun F, Youning L. Resistence phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shengyang, China. Antimicrob Agents Chemother,2004, 48 : 4040-4041.
  • 6Yamazaki T, Sasaki T, Takahata M. Activity of Garenoxacin against Macrolide-Susceptible and -Resistant Mycoplasma pneumoiae. Antimicrob Agents Chemother, 2007, 51: 2278- 2279.
  • 7Bebear CM, Pereyre S. Mechanisms of drug resistance in Myeoplasma pneumoniae. Curt Drug Targets Infect Disord, 2005, 5 : 263-271.
  • 8Lieberman D, Liebennan D, Printz S, et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am J Respir Crit Care Med, 2003,167: 406-410.
  • 9Amsden GW. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother, 2005,55:10-21.
  • 10Healy DP. Macrolide immunomodulation of chronic respiratory diseases. Curt Infect Dis Rep, 2007,9:7-13.

共引文献414

同被引文献73

引证文献15

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部